Genomic Medicine Sweden
Genomic Medicine Sweden, GMS, is paving the way for improved diagnostics, care and treatment.
Sweden’s ambitious national collaboration for genomic medicine
Our strategic mission is to foster collaboration between healthcare providers, academia and industry and realize precision medicine by effectively utilizing the rapidly advancing sequencing technologies to provide the highest standards of genomic testing in routine clinical care throughout Sweden.
Industry
Through an active collaboration with industry, GMS will develop and provide tomorrow´s solutions for the diagnostics and treatment of various diseases.
Healthcare
A close collaboration between healthcare and academia is central in introducing new forms of diagnostics as the basis for an individualized choice of treatment.
Academia
GMS forms a strong basis for researchers to better understand why disease arises and how new forms of treatment can be developed.
News
GMS and Illumina collaborate to develop whole-genome sequencing for patients with acute leukemia
A new study has been initiated to evaluate whole-genome and RNA-sequencing as a first line diagnostic approach for patients in Sweden with acute leukemia. The study will assess the potential of these sequencing approaches to replace current diagnostic...
Regional centers
Seven regional centers are the GMS engine
GMS is comprised of seven regional Genomic Medicine Centers (GMC). These joint centers act as the primary point of contact for sequencing patient samples within healthcare, thereby creating an integrated platform for both healthcare delivery and advanced medical research. Each GMC is a collaboration between a region with university hospital care, a university with a faculty of medicine, and SciLifeLab.
Participating partners
In collaboration with:
